PEPT Among Its Peers
End-of-day Nov 18, 2026 · 1 ETFs by Max
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.1% | −3.6% | +3.2% | — | — | — | — | — | — | +7.4% |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$137 of every $1,000 in PEPT is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 13.68% | $1,367.79 | 315 | $446K |
| 2 | ASNDAscendis Pharma A/S | Healthcare | 11.36% | $1,136.34 | 1,366 | $370K |
| 3 | NVONovo Nordisk A/S | Healthcare | 10.13% | $1,013.26 | 8,116 | $330K |
| 4 | PODDInsulet | Healthcare | 7.84% | $783.77 | 1,758 | $256K |
| 5 | RYTMRhythm Pharmaceuticals | Healthcare | 6.03% | $603.08 | 1,686 | $197K |
| 6 | PTGXProtagonist Therapeutics | Healthcare | 5.97% | $596.58 | 1,560 | $194K |
| 7 | SANSanofi | Financial Services | 5.89% | $588.75 | 2,015 | $192K |
| 8 | DARDarling Ingredients | Consumer Defensive | 3.97% | $396.80 | 2,449 | $129K |
| 9 | VKTXViking Therapeutics | Healthcare | 3.69% | $368.82 | 4,473 | $120K |
| 10 | —Bachem | — | 3.46% | $345.91 | 1,228 | $113K |
| 11 | —Ipsen | — | 2.98% | $298.01 | 538 | $97K |
| 12 | PBLSParabilis Medicines | Healthcare | 2.66% | $265.69 | 3,066 | $87K |
| 13 | ZEALZealand Pharma A/S | — | 2.59% | $258.90 | 2,497 | $84K |
| 14 | AUPHAurinia Pharmaceuticals | Healthcare | 2.21% | $220.70 | 4,672 | $72K |
| 15 | NEUNeuren Pharmaceuticals | Basic Materials | 2.03% | $203.30 | 4,326 | $66K |
PEPT has no close peers in our data yet: […]
Not enough history yet: PEPT needs a year of prices.
PEPT does not pay a distribution.
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
No payouts on record: […]
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 13.68% |
| 2 | ASND | Ascendis Pharma A/S | 11.36% |
| 3 | NVO | Novo Nordisk A/S | 10.13% |
| 4 | PODD | Insulet | 7.84% |
| 5 | RYTM | Rhythm Pharmaceuticals | 6.03% |
| 6 | PTGX | Protagonist Therapeutics | 5.97% |
| 7 | SAN | Sanofi | 5.89% |
| 8 | DAR | Darling Ingredients | 3.97% |
| 9 | VKTX | Viking Therapeutics | 3.69% |
| 10 | PBLS | Parabilis Medicines | 2.66% |